Jefferies analyst Michael Yee maintained a Buy rating on Gilead Sciences (GILD – Research Report) yesterday and set a price target of ...

We recently compiled a list of the 8 Best Humane Stocks to Invest in Now. In this article, we are going to take a look at ...

The global precision diagnostics and medicine market, valued at US$132.46 billion in 2023, is forecasted to grow at a robust CAGR of 11.1%, reaching US$145.53 billion in 2024 and an impressive US$246.

In recent years, the investment landscape has seen a significant shift towards socially responsible investing strategies.

The global precision diagnostics and medicine market, valued at US$132.46 billion in 2023, is forecasted to grow at a robust CAGR of 11.1%, ...

In this scenario, NV-387 stands apart in the field of antiviral ... Gilead and LEO Pharma Enter Into Strategic Partnership to Accelerate Development of Oral STAT6 Program With Potential in Multiple ...

A patent dispute between ViiV Healthcare and Gilead ... therapy, which could offset the decline, although it will face competition from other drugs including Pfizer's oral antiviral Paxlovid ...

Actor Mel Gibson recently opened up about a challenging chapter in his life, sharing details of his battle with COVID-19 and ...

The US government has placed an order with Merck & Co to buy 1.7 million courses of its antiviral therapy molnupiravir ... much of the early supply of Gilead Sciences' antiviral Veklury ...

(Yicai) Jan. 3 -- US pharmaceutical company Gilead Sciences has been given the greenlight by Chinese ... body’s immunity and eventually to death from various complications. As antiviral therapies ...